These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 136826)

  • 21. [Surgical therapy of metastasizing kidney cancer. A retrospective study].
    Flamm J
    Wien Med Wochenschr; 1984 Apr; 134(7):147-51. PubMed ID: 6204463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Carcinoma of the kidney in the adult: results of current treatment. 120 cases (author's transl)].
    Cukier J; Amiel JL; Bronstein M; Droz JP
    Nouv Presse Med; 1979 Jan; 8(5):319-21. PubMed ID: 554090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anatomical classification of adenocarcinomas of the kidney. Reflections apropos of 270 surgically treated cases].
    Cukier J; Charbit L
    J Urol (Paris); 1986; 92(1):1-6. PubMed ID: 3722846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Possibilities of DNA impulse cytophotometry in kidney cancers].
    Kiesewetter F; Hornstein OP; Hermanek P; Herrlinger A; Eberhard S
    Urologe A; 1987 May; 26(3):162-7. PubMed ID: 3603902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malignancy Rate, Histologic Grade, and Progression of Bosniak Category III and IV Complex Renal Cystic Lesions.
    Mousessian PN; Yamauchi FI; Mussi TC; Baroni RH
    AJR Am J Roentgenol; 2017 Dec; 209(6):1285-1290. PubMed ID: 28981360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of histological grade and nuclear grade in renal adenocarcinoma.
    Marroncle M; Irani J; Dore B; Levillain P; Goujon JM; Aubert J
    J Urol; 1994 May; 151(5):1174-6. PubMed ID: 8158753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Updates in Pathologic Staging and Histologic Grading of Renal Cell Carcinoma.
    Taneja K; Williamson SR
    Surg Pathol Clin; 2018 Dec; 11(4):797-812. PubMed ID: 30447842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor necrosis adds prognostically significant information to grade in clear cell renal cell carcinoma: A study of 842 consecutive cases from a single institution. Khor LY, Dhakal HP, Jia X, Reynolds JP, McKenney JK, Rini BI, Magi-Galluzzi C, Przybycin CG.Am J Surg Pathol. September 2016;40(9):1224-1231.
    Kryvenko ON
    Urol Oncol; 2017 Jun; 35(6):454-455. PubMed ID: 28416108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal cell carcinoma: tumor size, stage and survival. Members of the Cancer Incidence and End Results Committee.
    Guinan PD; Vogelzang NJ; Fremgen AM; Chmiel JS; Sylvester JL; Sener SF; Imperato JP
    J Urol; 1995 Mar; 153(3 Pt 2):901-3. PubMed ID: 7853570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Volume-weighted mean nuclear volume as a prognostic factor in renal cell carcinoma.
    Soda T; Fujikawa K; Ito T; Sasaki M; Nishio Y; Miyakawa M
    Lab Invest; 1999 Jul; 79(7):859-67. PubMed ID: 10418826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases.
    Delahunt B; Eble JN; McCredie MR; Bethwaite PB; Stewart JH; Bilous AM
    Hum Pathol; 2001 Jun; 32(6):590-5. PubMed ID: 11431713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.
    Lerner SE; Hawkins CA; Blute ML; Grabner A; Wollan PC; Eickholt JT; Zincke H
    J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chromophobe cell renal carcinoma. Clinico-pathologic study of 36 cases].
    Alvarado-Cabrero I; Atencio-Chan A; Rodríguez C; Sosa-Romero A
    Gac Med Mex; 2002; 138(5):421-5. PubMed ID: 12404725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cancer of the kidney, prognostic value of nuclear grading for the early diagnosis of metastasis].
    Alexandre L; Vieillefond A; Benoît G; Yataghene Y; Bensadoun H; Blanchet P; Jardin A
    Presse Med; 1994 Apr; 23(15):699-701. PubMed ID: 8072974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor Necrosis Adds Prognostically Significant Information to Grade in Clear Cell Renal Cell Carcinoma: A Study of 842 Consecutive Cases From a Single Institution.
    Khor LY; Dhakal HP; Jia X; Reynolds JP; McKenney JK; Rini BI; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Sep; 40(9):1224-31. PubMed ID: 27428737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Quantitative morphological criteria of the degree of malignancy of kidney cancer].
    Dikshteĭn EA; Vlodavskiĭ EA; Svistunov IV
    Arkh Patol; 1982; 44(12):12-7. PubMed ID: 7165528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognosticfactors in patients with renal cell carcinoma: is TNM (1997) staging relevant in Indian subpopulation?
    Srivastava A; Mandhani A; Kapoor R; Jain M; Dubey D; Srivastava A; Raghavendra M; Kumar A
    Indian J Cancer; 2004; 41(3):99-103. PubMed ID: 15472406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reliability of aspiration biopsy cytology in the grading of renal adenocarcinoma.
    Nurmi M; Tyrkkö J; Puntala P; Sotarauta M; Antila L
    Scand J Urol Nephrol; 1984; 18(2):151-6. PubMed ID: 6463599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fuhrman grading is not appropriate for chromophobe renal cell carcinoma.
    Delahunt B; Sika-Paotonu D; Bethwaite PB; McCredie MR; Martignoni G; Eble JN; Jordan TW
    Am J Surg Pathol; 2007 Jun; 31(6):957-60. PubMed ID: 17527087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.